This site uses cookies. By continuing to browse the site you are agreeing to our policy on the use of cookies. Find out more here.

eMC - trusted, up to date and comprehensive information about medicines
Link to eMC medicine guides website
eMC homepage
New eMC coming June 2013...

Lundbeck Limited

Lundbeck House, Caldecotte Lake Business Park, Caldecotte, Milton Keynes, MK7 8LG
Telephone: +44 (0)1908 649 966
Fax: +44 (0)1908 647 888
WWW: http://www.lundbeck.co.uk
Medical Information Direct Line: +44 (0)1908 638 972
Medical Information e-mail: ukmedicalinformation@lundbeck.com
Customer Care direct line: +44 (0)1908 638 935

Before you contact this company: often several companies will market medicines with the same active ingredient. Please check that this is the correct company before contacting them. Why?

Patient Information Leaflet last updated on the eMC: 27/09/2013
PIL Cipralex 5, 10 and 20 mg film-coated tablets

When a pharmaceutical company changes an SPC or PIL, a new version is published on the eMC. For each version, we show the dates it was published on the eMC and the reasons for change.

Updated on 27/09/2013 and displayed until Current
Reasons for adding or updating:
  • Change to section 1 - what the product is used for
  • Change to section 2 - what you need to know - warnings and precautions
  • Change to section 2 - interactions with other medicines, food or drink
  • Change to section 4 - possible side effects
  • Change to section 4 - how to report a side effect
  • Change to section 6 - date of revision
Updated on 21/09/2012 and displayed until 27/09/2013
Reasons for adding or updating:
  • Change to date of revision
  • Change to information about pregnancy or lactation
Updated on 23/02/2012 and displayed until 21/09/2012
Reasons for adding or updating:
  • Change to date of revision
  • Change to warnings or special precautions for use
  • Change of contra-indications
  • Change to side-effects
  • Change to drug interactions
Updated on 05/10/2011 and displayed until 23/02/2012
Reasons for adding or updating:
  • Change to packaging
Updated on 21/02/2011 and displayed until 05/10/2011
Reasons for adding or updating:
  • Improved Electronic Presentation
Updated on 28/05/2008 and displayed until 21/02/2011
Reasons for adding or updating:
  • Transfer to upgraded management system
  • PIL Retired pending re-submission
Updated on 15/12/2007 and displayed until 28/05/2008
Reasons for adding or updating:
  • Change to warnings or special precautions for use
  • Change to side-effects
  • Change to Further Information section
  • Change to date of revision
  • Changes to therapeutic indications
Updated on 14/06/2002 and displayed until 15/12/2007
Reasons for adding or updating:
  • New PIL for new product

Active Ingredients/Generics